乳腺癌围化疗期中西医结合冰冻治疗管理专家共识

doi:10.3969/j.issn.1006-5725.2026.05.001

Abstract

Abstract:

Breast cancer stands as one of the most prevalent malignant tumors among women globally. Chemotherapy， being a crucial element in breast cancer treatment， is frequently linked to diverse side-effects， including alopecia and hand-foot syndrome. These adverse reactions can significantly undermine patients' psychological health and quality of life. In response to this issue， international research has indicated that cooling therapy can effectively decrease the incidence of alopecia； however， 16% to 84% of patients still encounter hair loss. Clinical practice has proven that combining traditional Chinese medicine with chemotherapy in breast cancer treatment can further reduce the incidence of alopecia and hand-foot syndrome， relieve patient discomfort， improve the quality of life， and offer chemosensitizing and efficacy-enhancing effects. Nevertheless， there is a deficiency of standardized protocols in practical applications. To further standardize and optimize clinical practice， a multidisciplinary expert panel consisting of breast oncology specialists， oncological traditional Chinese medicine experts， and nursing science professionals was assembled. After multiple rounds of deliberation and revision， this consensus document was finally formulated. This consensus standardizes Integrative Medicine Cooling Therapy Management from multiple perspectives， such as scope， terminology and definitions， theoretical bases， implementation procedures， characteristic TCM therapies， and efficacy assessment. It especially emphasizes the implementation procedures during chemotherapy and characteristic TCM treatment methods. The document puts forward seven evidence-based recommendations to offer standardized guidance for clinical practice.

Key words: breast cancer, chemotherapy-induced alopecia, hand-foot syndrome, integrative medicine cooling management, consensus

CLC Number:

R737.9

Huan LIN,Hongsheng LI,Mei HUANG,Guochun ZHANG,Neng WANG,Guanqun HUANG,Juan XU,Qingfeng ZOU,Xingyuan SHI,Wenguang HE,Feng LI,Yanqing CAI,xiaoping HUANG,Qiongdiao HUANG,Zejuan YANG,Runmei LUO,Jiewen ZHANG,Yi TANG,Chaoliang XU,Hongfei GAO,Weicai CHEN,Hao HU,Yongsheng YAO,Chu HUANG,Jiewen HUANG,Yichao HUANG,Yeyan LEI,Ming LUO,Zhe WU,Nangui YUAN,Yongting LIN. Consensus on integrative medicine cooling therapy management during the peri-chemotherapy period for breast cancer[J]. The Journal of Practical Medicine, 2026, 42(5): 723-733.

Figures/Tables 2

References 51

[1]	ROSE L， LUSTBERG M， RUDDY K J， et al. Hair loss during and after breast cancer therapy［J］. Support Care Cancer， 2023，31（3）：186. doi： 10.1007/s00520-023-07634-5 . doi: 10.1007/s00520-023-07634-5
[2]	UGUREL S， PFÖHLER C， GUTZMER R. Cutaneous adverse events to systemic anticancer therapies ： Hand-foot syndrome and nail changes［J］. Dermatologie （Heidelb）， 2024，75（6）：451-458. doi： 10.1007/s00105-024-05351-6 . doi: 10.1007/s00105-024-05351-6
[3]	BAJPAI J， KAGWADE S， CHANDRASEKHARAN A， et al."Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia"［J］. Breast， 2020，49：187-193.doi： 10.1016/j.breast.2019.12.004 . doi: 10.1016/j.breast.2019.12.004
[4]	NANGIA J， WANG T， OSBORNE C， et al. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer： The SCALP Randomized Clinical Trial［J］. JAMA， 2017，317（6）：596-605. doi： 10.1001/jama.2016.20939 . doi: 10.1001/jama.2016.20939
[5]	RICE B A， VERHOEVE E S， DELUCA A N， et al. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy［J］. Breast Cancer Res Treat， 2018，167（1）：117-122. doi： 10.1007/s10549-017-4506-z . doi: 10.1007/s10549-017-4506-z
[6]	CARTON E， BLAS A M， PERRET C， et al. Effectiveness of increasing the scalp cooling duration to prevent alopecia during adjuvant chemotherapy for breast cancer： A randomized pilot study［J］. Support Care Cancer， 2024，32（7）：410.doi： 10.1007/s00520-024-08579-z . doi: 10.1007/s00520-024-08579-z
[7]	SHAH V V， WIKRAMANAYAKE T C， DELCANTO G M， et al. Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia： A review of controlled clinical trials［J］. J Eur Acad Dermatol Venereol， 2018，32（5）：720-734.doi： 10.1111/jdv.14612 . doi: 10.1111/jdv.14612
[8]	胡智慧，巴根那，李冀，等. 中医治疗对乳腺癌化疗患者的增效与减毒作用研究进展［J］. 医学综述， 2019，25（13）：2674-2678.doi：10.3969/j.issn.1006-2084.2019.13.035 doi: 10.3969/j.issn.1006-2084.2019.13.035
[9]	金丹，姜大庆. 乳腺癌术后中医药治疗概况［J］. 实用中医内科杂志， 2017，31（2）：86-87.doi：10.13729/j.issn.1671-7813. 2017. 02.33 . doi: 10.13729/j.issn.1671-7813. 2017. 02.33
[10]	HENRIQUES A C， RIBEIRO D， PEDROSA J， et al. Mitosis inhibitors in anticancer therapy： When blocking the exit becomes a solution［J］. Cancer Lett， 2019，440-441：64-81.doi： 10.1016/j.canlet.2018.10.005 . doi: 10.1016/j.canlet.2018.10.005
[11]	VANN K R， OVIATT A A， OSHEROFF N. Topoisomerase Ⅱ Poisons： Converting Essential Enzymes into Molecular Scissors［J］. Biochemistry， 2021，60（21）：1630-1641.doi： 10.1021/acs.biochem.1c00240 . doi: 10.1021/acs.biochem.1c00240
[12]	GAO Q， ZHOU G， LIN S J， et al. How chemotherapy and radiotherapy damage the tissue： Comparative biology lessons from feather and hair models［J］. Exp Dermatol， 2019，28（4）：413-418.doi： 10.1111/exd.13846 . doi: 10.1111/exd.13846
[13]	SREEDHAR A， AGUILERA-AGUIRRE L， SINGH K K. Mitochondria in skin health， aging， and disease［J］. Cell Death Dis， 2020，11（6）：444.doi： 10.1038/s41419-020-2649-z . doi: 10.1038/s41419-020-2649-z
[14]	CHIN H S， CHENG J， HSU S H， et al. MCL-1 safeguards activated hair follicle stem cells to enable adult hair regeneration［J］. Nat Commun， 2025，16（1）：2829. doi： 10.1038/s41467-025-58150-5 . doi: 10.1038/s41467-025-58150-5
[15]	DU F， LI J， ZHANG S， et al. Oxidative stress in hair follicle development and hair growth： Signalling pathways， intervening mechanisms and potential of natural antioxidants［J］. J Cell Mol Med， 2024，28（12）：e18486.doi： 10.1111/jcmm.18486 . doi: 10.1111/jcmm.18486
[16]	BASHIR D J， MANZOOR S， SARFARAJ M， et al. Magnoflorine-Loaded Chitosan Collagen Nanocapsules Ameliorate Cognitive Deficit in Scopolamine-Induced Alzheimer's Disease-like Conditions in a Rat Model by Downregulating IL-1β， IL-6， TNF-α， and Oxidative Stress and Upregulating Brain-Derived Neurotrophic Factor and DCX Expressions［J］. ACS Omega， 2023，8（2）：2227-2236. doi： 10.1021/acsomega.2c06467 . doi: 10.1021/acsomega.2c06467
[17]	INOUE R， ABE H， KONISHI M， et al. Capecitabine-induced hand-foot syndrome does not emerge in the complex regional pain syndrome-affected limb： A case report［J］. Mol Clin Oncol， 2021，15（6）：254. doi： 10.3892/mco.2021.2416 . doi: 10.3892/mco.2021.2416
[18]	BROUSSY S. Vascular Endothelial Growth Factor （VEGF） and VEGF Receptor Inhibitors in Health and Disease［J］. Pharmaceuticals （Basel）， 2024，17（7）：959. doi： 10.3390/ph17070959 . doi: 10.3390/ph17070959
[19]	HANG A， FELDMAN S， AMIN A P， et al. Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders［J］. Pharmaceuticals （Basel）， 2023，16（8）：1140.doi： 10.3390/ph16081140 . doi: 10.3390/ph16081140
[20]	LI L， WANG S， ZHOU W. Balance Cell Apoptosis and Pyroptosis of Caspase-3-Activating Chemotherapy for Better Antitumor Therapy［J］. Cancers （Basel）， 2022，15（1）：26. doi： 10.3390/cancers15010026 . doi: 10.3390/cancers15010026
[21]	GORZELANNY C， MESS C， SCHNEIDER S W， et al. Skin Barriers in Dermal Drug Delivery： Which Barriers Have to Be Overcome and How Can We Measure Them？［J］. Pharmaceutics， 2020，12（7）：684.doi： 10.3390/pharmaceutics12070684 . doi: 10.3390/pharmaceutics12070684
[22]	LI X， YE Y， LIU X， et al. Low-frequency electromagnetic fields promote hair follicles regeneration by injection a mixture of epidermal stem cells and dermal papilla cells［J］. Electromagn Biol Med， 2020， 39（4）：251-256.doi： 10.1080/15368378. 2020. 1793165 . doi: 10.1080/15368378. 2020. 1793165
[23]	ZHU X， BÜHRER C， WELLMANN S. Cold-inducible proteins CIRP and RBM3， a unique couple with activities far beyond the cold［J］. Cell Mol Life Sci， 2016，73（20）：3839-3859. doi： 10. 1007/s00018-016-2253-7 . doi: 10. 1007/s00018-016-2253-7
[24]	CHANG W L， KO C H. The Role of Oxidative Stress in Vitiligo： An Update on Its Pathogenesis and Therapeutic Implications［J］. Cells， 2023，12（6）：936.doi： 10.3390/cells12060936 . doi: 10.3390/cells12060936
[25]	王丰莲. 八珍汤改善乳腺癌化疗患者毛发超微结构的研究［J］. 实用药物与临床， 2018， 21（7）： 794-797.doi： 10.14053/j.Cnki.Ppcr.201807018 . doi: 10.14053/j.Cnki.Ppcr.201807018
[26]	陈前军，裴晓华. 早期乳腺癌中医辨证内治专家共识［J］. 现代中医临床， 2020，27（3）：5-8.doi：10.3969/j.issn.2095-6606. 2020. 03.002 . doi: 10.3969/j.issn.2095-6606. 2020. 03.002
[27]	刘益铭，李秋华，梁丽喆，等. 乳腺癌痰瘀互结的病理、病机及治疗［J］. 世界中医药，2021，16（21）：3127-3130.doi： 10.3969/j.issn.1673-7202.2021.21.004 . doi: 10.3969/j.issn.1673-7202.2021.21.004
[28]	蔡丽珍，白瑞娜，张路，等. 基于“痰夹瘀血”理论探讨乳腺癌相关淋巴水肿因机治疗［J］. 陕西中医，2023，44（10）：1420-1423.doi： 10.3969/j.issn.1000-7369.2023.10.019 . doi: 10.3969/j.issn.1000-7369.2023.10.019
[29]	AUVINEN P K， MÄHÖNEN U A， SOININEN K M， et al. The effectiveness of a scalp cooling cap in preventing chemotherapy-induced alopecia［J］. Tumori， 2010，96（2）：271-275.doi： 10.1177/030089161009600214 . doi: 10.1177/030089161009600214
[30]	ALESSANDRINI A， STARACE M， CERÈ G， et al. Management and Outcome of Taxane-Induced Nail Side Effects： Experience of 79 Patients from a Single Centre［J］. Skin Appendage Disord， 2019，5（5）：276-282.doi： 10.1177/030089161009600214 . doi: 10.1177/030089161009600214
[31]	SCOTTÉ F， TOURANI J M， BANU E， et al. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand［J］. J Clin Oncol， 2005，23（19）：4424-4429. doi： 10.1200/JCO.2005.15.651 . doi: 10.1200/JCO.2005.15.651
[32]	SCOTTÉ F， BANU E， MEDIONI J， et al. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot［J］. Cancer， 2008，112（7）：1625-1631.doi： 10.1002/cncr.23333 . doi: 10.1002/cncr.23333
[33]	DUNNILL C， IBRAHEEM K， PEAKE M， et al. Cooling-mediated protection from chemotherapy drug-induced cytotoxicity in human keratinocytes by inhibition of cellular drug uptake［J］. PLoS One， 2020，15（10）：e0240454. doi： 10.1371/journal.pone. 0240454 . doi: 10.1371/journal.pone. 0240454
[34]	KOMEN M M， SMORENBURG C H， VAN DEN HURK C J， et al. Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia［J］. Oncologist， 2013，18（7）：885-891. doi： 10.1634/theoncologist.2012-0332 . doi: 10.1634/theoncologist.2012-0332
[35]	BITTO F F， KÖNIG A， PHAN-BREHM T， et al. EVA-Scalp： Evaluation of Patient Satisfaction with a Scalp Cooling Device to Prevent Chemotherapy-Induced Alopecia in Breast Cancer Patients［J］. Breast Care （Basel）， 2020，15（2）：171-177. doi： 10. 1159/000501393 . doi: 10. 1159/000501393
[36]	SMETANAY K， JUNIO P， FEIßT M， et al. COOLHAIR： A prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing （neo）adjuvant chemotherapy for early breast cancer［J］. Breast Cancer Res Treat， 2019，173（1）：135-143.doi： 10.1007/s10549-018-4983-8 . doi: 10.1007/s10549-018-4983-8
[37]	VAN DEN HURK C J， BREED W P， NORTIER J W. Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia［J］. Support Care Cancer， 2012，20（12）：3255-3260. doi： 10.1007/s00520-012-1465-0 . doi: 10.1007/s00520-012-1465-0
[38]	KATE S， PATIL R， PATHAN D， et al. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia- A single center prospective study［J］. Cancer Treat Res Commun， 2021，26：100280. doi： 10.1016/j.ctarc.2020.100280 . doi: 10.1016/j.ctarc.2020.100280
[39]	KEIM S， HEMPEL L， EBNER F， et al. Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia for Women and Men with Various Cancer Entities： A Two-Year Survey of an Outpatient Cancer Center in Germany［J］. Oncol Res Treat， 2022，45（7/8）：395-399. doi： 10.1159/000523759 . doi: 10.1159/000523759
[40]	LEE V G H， LOH J， HUI F， et al. Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers-an Asian tertiary institution experience［J］. Support Care Cancer， 2024，32（11）：762.doi： 10.1007/s00520-024-08940-2 . doi: 10.1007/s00520-024-08940-2
[41]	ORLANDO L， LOPARCO D， FEDELE P， et al. Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia［J］. Future Oncol， 2019，15（29）：3337-3344.doi： 10.2217/fon-2019-0066 . doi: 10.2217/fon-2019-0066
[42]	GIANOTTI E， RAZZINI G， BINI M， et al. Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Undergoing Curative Chemotherapy： A Multicenter Interventional Study［J］. Asia Pac J Oncol Nurs， 2019，6（3）：277-282. doi： 10.4103/apjon.apjon_4_19 . doi: 10.4103/apjon.apjon_4_19
[43]	VAN DEN HURK C J， PEERBOOMS M， VAN DE POLL-FRANSE L V， et al. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients-results of the Dutch Scalp Cooling Registry［J］. Acta Oncol， 2012，51（4）：497-504.doi： 10.3109/0284186X.2012.658966 . doi: 10.3109/0284186X.2012.658966
[44]	KOMEN M M C， VAN DEN HURK C J G， NORTIER J W R， et al. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia： A randomised trial in patients with breast cancer treated with adjuvant chemotherapy［J］. Support Care Cancer， 2019，27（5）：1919-1925. doi： 10. 1007/s00520-018-4432-6 . doi: 10. 1007/s00520-018-4432-6
[45]	VILLARREAL-GARZA C， MESA-CHAVEZ F， GARZA-LEDEZMA M R A， et al. Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention［J］. Breast Cancer Res Treat， 2021，185（2）：453-458. doi： 10.1007/s10549-020-05968-w . doi: 10.1007/s10549-020-05968-w
[46]	RIDDERHEIM M， BJURBERG M， GUSTAVSSON A. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe： A pilot study of a new digitized scalp-cooling system used in 74 patients［J］. Support Care Cancer， 2003，11（6）：371-7. doi： 10.1007/s00520-003-0451-y . doi: 10.1007/s00520-003-0451-y
[47]	中国医药教育协会烧伤专业委员会. 冻伤早期的临床诊疗全国专家共识［J］. 中华损伤与修复杂志（电子版），2022，17（1）：1-6.doi： 10.3877/cma.j.issn.1673-9450.2022.01.001 . doi: 10.3877/cma.j.issn.1673-9450.2022.01.001
[48]	ELSTAD M， ZILAKOS I， BERGERSEN T K. Oscillatory pattern of acral skin blood flow within thermoneutral zone in healthy humans［J］. Physiol Meas， 2017，38（5）：848-859. doi： 10.1088/1361-6579/aa5fee . doi: 10.1088/1361-6579/aa5fee
[49]	INGRASSIA J P， STEIN J A， LEVINE A， et al. Diagnosis and Management of Acral Pigmented Lesions［J］. Dermatol Surg J 2023，49（10）：926-931. doi： 10.1097/DSS.0000000000003891 . doi: 10.1097/DSS.0000000000003891
[50]	KLANIDHI K B， MONIAN S A， CHAKRAWARTY A. Acral vascular syndrome Lennert type T cell lymphoma-a case report［J］. J Egypt Natl Canc Inst， 2021，33（1）：8.doi： 10.1186/s43046-021-00063-7 . doi: 10.1186/s43046-021-00063-7
[51]	李忠友，蒋文涛，范海冬，等. 全身体表血管热扩张诱导血流重分配数值研究［C］//中国力学大会-2021+1论文集编委会. 中国力学大会- 2021+1 论文集（第五册）. 成都：四川大学出版社， 2022： 207.

Consensus on integrative medicine cooling therapy management during the peri-chemotherapy period for breast cancer

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 51

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Sheng NONG,Zhanxiong LI,Qi ZHANG,Zhendong LU,Minping HONG,Wubiao CHEN,Zilin LIU. Predictive performance of an interpretable BPNN model for axillary lymph node burden in breast cancer patients with 1 ~ 2 sentinel lymph node positive [J]. The Journal of Practical Medicine, 2026, 42(1): 45-55.
[2]	. Expert consensus on genetic testing for metastatic colorectal cancer patients based on tumor heterogeneity [J]. The Journal of Practical Medicine, 2025, 41(19): 2961-2966.
[3]	Guofen LIANG,Zhenhua YANG,Yibo WANG,Kaiyu HE,La ZHANG,Xusheng LIU,Yueyu GU,Xindong QIN,Guobin SU. Interpretation of 《Global consensus on multidisciplinary diagnostic criteria for urinary tract infections》 [J]. The Journal of Practical Medicine, 2025, 41(18): 2777-2785.
[4]	Yingchao WU,Liushan CHEN,Yuqi LIANG,Jieting CHEN,Junfeng HUANG,Qian ZUO,Qianjun CHEN. Development of an organoid⁃based pan⁃TKI precision screening platform to enhance therapeutic efficacy of ET+CDK4/6 inhibitors in HR⁺/HER2⁃low breast cancer [J]. The Journal of Practical Medicine, 2025, 41(18): 2786-2795.
[5]	Xinran ZHANG,Yan SHEN,Jiaojiao HU,Qingqing CHEN,Yangjie XIAO,Feng LU,Shasha YUAN,Xiaohong FU. Study on the applied value of combined clinical and ultrasound multiparameter constructed nomogram for predicting HER⁃2⁃positive breast cancer [J]. The Journal of Practical Medicine, 2025, 41(18): 2812-2819.
[6]	Jingshuo LI,Shoushi LIU,Hongwei. GUO. Advances in the mechanism and therapeutic potential of Erianin⁃induced apoptosis in breast cancer cells [J]. The Journal of Practical Medicine, 2025, 41(14): 2132-2137.
[7]	Hai QIU,Yifei GUI,Yuan. LIU. Predictors of sentinel lymph node metastasis in clinical T1⁃2 N0 breast cancer patients with preoperatively normal axillary ultrasound [J]. The Journal of Practical Medicine, 2025, 41(14): 2143-2151.
[8]	Yuling DUAN,Xuezhi ZHOU,Yongyi LI,Lixia MA,Desheng YANG,Jiao CHENG,Yan WU,Tao LIU,Guoyuan JIANG,Mei. WANG. Clinical value analysis of different MRI measurement methods in evaluating the efficacy of neoadjuvant therapy for breast cancer [J]. The Journal of Practical Medicine, 2025, 41(14): 2152-2159.
[9]	Qisen FAN,Lan LAN,Jingxiang WU,Yuan QIU,Guiping XU,Jiang WANG,Duozhi WU,Jinhui LUO,Jian RAN,Yingfen LI,Peng PAN,Bing ZHANG,Yuelan ZHOU,Yiwen ZHANG,Xuebing XU,Yatao LIU,Yingbin WANG,Yan WANG,Yulong WANG,Youyang HU,Shoushi WANG,Hongwei MENG,Haixia XU,Peijia TANG,Xiaoxue ZHUANG,Canzhou. ZHANG. Consensus of experts on the management of thoracic anesthesia with spontaneous respiration [J]. The Journal of Practical Medicine, 2025, 41(13): 1945-1951.
[10]	Lu JIANG,Weipeng LYU,Sijing CHEN,Yanhua FANG,Shanshan LIANG. Inhibitory effect of disitamab vedotin on breast cancer cells with different HER⁃2 expression levels in tumor organoid culture system [J]. The Journal of Practical Medicine, 2025, 41(12): 1808-1815.
[11]	Yaqian DENG,Wenxiao LI,Zelin XU,Jinmei MA,Tingting DU,Wen LIU,Jun LI. Predictive value of growth orientation quantification combined with S⁃Detect technique for axillary lymph node metastasis in breast cancer [J]. The Journal of Practical Medicine, 2025, 41(1): 100-107.
[12]	Zixu SONG,Guangzheng ZHU,Chenxu GUO,Jiaqi WU,Ligong ZHANG,Jun. QIAN. Expression of SLC35A2 and PFDN2 in breast cancer and its relationship with clinical observables and prognosis [J]. The Journal of Practical Medicine, 2024, 40(4): 496-502.
[13]	Fen LIU,Hui ZHAO,Limin. GUO. Relationship between multi⁃omics combined detection and clinicopathological characteristics， neoadjuvant chemotherapy effect of breast cancer [J]. The Journal of Practical Medicine, 2024, 40(24): 3539-3546.
[14]	Yinghua ZENG,Wenji LI,Li. ZHENG. The Impact of the timing of initial dressing change following PICC catheterization on postoperative breast cancer patients [J]. The Journal of Practical Medicine, 2024, 40(19): 2772-2777.
[15]	Che CHEN,Dehong LUO,Huangfei YU,Qin ZHANG,Xiaochi HU,Shenghua YU,Yajun. LI. Clinical Application of automatic delineation in whole breast radiotherapy with simultaneous integrated boost to the medial tumor beds [J]. The Journal of Practical Medicine, 2024, 40(17): 2406-2411.